Kenya advances local manufacturing of health products and technologies

Kenya has launched a five-year local manufacturing strategy (2026–2030) to expand domestic production of medicines, vaccines, diagnostics and medical devices, targeting 70% utilisation of existing capacity and WHO regulatory benchmark achievement. The country currently imports 70–80% of pharmaceuticals consumed despite being Africa's third-largest pharmaceutical exporter, and the strategy aims to close that gap through capacity utilisation, Good Manufacturing Practice certification, and multi-year public procurement commitments. Kenya just guaranteed multi-year public procurement contracts for local pharma makers as part of its manufacturing push - if you sell into East Africa's health systems, you now have a customer willing to buy local at scale rather than import. The regulatory bar is rising too (WHO Maturity Level 3); suppliers who help manufacturers hit that standard have a new market.